{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:30:04Z","timestamp":1764783004763},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.colsurfb.2007.05.009","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T16:24:31Z","timestamp":1179591871000},"page":"208-214","source":"Crossref","is-referenced-by-count":13,"title":["Enhanced dissolution of Oxcarbazepine microcrystals using a static mixer process"],"prefix":"10.1016","volume":"59","author":[{"given":"D.","family":"Douroumis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2007.05.009_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"Amidon","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0169-409X(02)00070-4","article-title":"Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I. Biopharmaceutics and formulation considerations","volume":"54","author":"Martinez","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jps.10274","article-title":"Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process","volume":"92","author":"Rasenack","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(03)00005-X","article-title":"Microcrystals for dissolution rate enhancement of poorly water-soluble drugs","volume":"254","author":"Rasenack","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0939-6411(02)00063-2","article-title":"A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid","volume":"54","author":"Rogers","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib8","series-title":"Fine Particles Science and Technology\u2014From Micro to Nanoparticles","first-page":"761","author":"Horn","year":"1996"},{"key":"10.1016\/j.colsurfb.2007.05.009_bib9","doi-asserted-by":"crossref","first-page":"B176","DOI":"10.1088\/0022-3727\/26\/8B\/029","article-title":"Rapid precipitation of biochemicals","volume":"26","author":"Mahajan","year":"1993","journal-title":"J. Phys. D Appl. Phys."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib10","unstructured":"B. K\u00fchn, Verfahren und Vorrichtung zur In-Situ-Formulierung einer Arzneistoffl\u00f6sung zur parenteralen Applikation, German Patent No. WO 99\/32175 A1 (1999)."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib11","first-page":"665","article-title":"A new formulation concept with drugs with poor water soloubility for parenteral application","volume":"60","author":"J\u00fcrgens","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.colsurfb.2007.05.009_bib12","first-page":"64","article-title":"Hydrosols\u2014alternatives for the parenteral application of poorly water soluble drugs","volume":"40","author":"Gassmann","year":"1994","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2006.02.004","article-title":"Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique","volume":"63","author":"Douroumis","year":"2006","journal-title":"Eur. J. Pharm. Biophys."},{"year":"1999","series-title":"Turbulent Mixing and Chemical Reactions","author":"Baldyga","key":"10.1016\/j.colsurfb.2007.05.009_bib14"},{"key":"10.1016\/j.colsurfb.2007.05.009_bib15","unstructured":"P.H. Stahl, Novartis\u2014Pharmaceutische Entwicklung, 1972."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib16","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1023\/A:1021410028371","article-title":"Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs","volume":"19","author":"Rasenack","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0021-9797(78)90010-3","article-title":"The surface tension of aqueous hydroxypropyl cellulose solutions","volume":"67","author":"Chang","year":"1978","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-5173(83)90159-X","article-title":"Absorption of non-anionic water soluble cellulose polymers at the solid water interface and their effect on suspension stability","volume":"15","author":"Law","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1023\/A:1016064930502","article-title":"Albumine nanospheres as carriers for passive drug targeting: an optimized manufacturing technique","volume":"13","author":"M\u00fcller","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/02652048609031572","article-title":"Preparation and in vitro evaluation of polylactic acidmitomycin C microscapsules","volume":"3","author":"Tsai","year":"1986","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0939-6411(02)00128-5","article-title":"Preparation and characterization of sterile sub-200nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy","volume":"55","author":"Konan","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib22","first-page":"307","article-title":"Evaluation of in vitro-in vivo correlation and anticonvulsive effectof carbamazepine after cogrinding with microcrystalline cellulose","volume":"9","author":"Barzegar-Jalali","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pol.1959.1203913521","article-title":"Infrared spectra of crystalline polysaccharides","volume":"39","author":"Liang","year":"1959","journal-title":"J. Polym. Sci."},{"key":"10.1016\/j.colsurfb.2007.05.009_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/03639040500215958","article-title":"Miscibility behaviour and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions","volume":"31","author":"Karavas","year":"2005","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776507002044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776507002044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T03:28:19Z","timestamp":1546831699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776507002044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0927776507002044"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2007.05.009","relation":{},"ISSN":["0927-7765"],"issn-type":[{"type":"print","value":"0927-7765"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}